Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Evolution in the Management of Type 2 Diabetes Mellitus: From Algorithmic to Individualized Approach


Affiliations
1 President-Medical & Regulatory Affairs, Dept. of Scientific, Aristo Pharmaceuticals Private Limited,, India
     

   Subscribe/Renew Journal


Managing type 2 diabetes mellitus (T2DM) is a serious challenge due to the progressive nature of the disease and its effects on multiple organs. Advances in diabetes monitoring, therapy, and technology have accelerated the shift toward patientcentered care. In order to reduce diabetes distress, an individualized strategy offers a unique management plan for each patient improving medication adherence, patient satisfaction, and physical health outcomes. This editorial focuses on an individualized approach and the key factors that must be taken into account for diabetes management.

Keywords

type 2 diabetes mellitus, individualized approach, antidiabetic agents, complications.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, Pavkov ME, Ramachandaran A, Wild SH, James S, Herman WH, Zhang P, Bommer C, Kuo S, Boyko EJ, Magliano DJ. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan;183:109119. DOI: 10.1016/j. diabres.2021.109119.
  • Subramanian S, Hirsch IB. Personalized Diabetes Management: Moving from Algorithmic to Individualized Therapy. Diabetes Spectr. 2014 May;27(2):87-91. DOI: 10.2337/diaspect.27.2.87.
  • Powell PW, Corathers SD, Raymond J, Streisand R. New approaches to providing individualized diabetes care in the 21st century. Curr Diabetes Rev. 2015;11(4):222-30. DOI: 10.2174/1573399811666150421110316.
  • Kalra S, Bantwal G, Sahay RK, Bhattacharya S, Baruah MP, Sheikh S, Lathia T. Incorporating Integrated Personalised Diabetes Management (iPDM) in Treatment Strategy: A Pragmatic Approach. Indian J Endocrinol Metab. 2022 Mar- Apr;26(2):106-110. DOI: 10.4103/ijem.ijem_478_21.
  • Ke C, Narayan KMV, Chan JCN, Jha P, Shah BR. Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations. Nat Rev Endocrinol. 2022 Jul;18(7):413-432. DOI: 10.1038/s41574- 022-00669-4.
  • Williams DM, Jones H, Stephens JW. Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations. Diabetes Metab Syndr Obes. 2022 Feb 4;15:281-295. DOI: 10.2147/DMSO.S331654.
  • Makkar BM,et al. RSSDI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2022. International Journal of Diabetes in Developing Countries. 2022October;42(1):S1–S143.
  • Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022 Nov;102(5S):S1-S127. DOI: 10.1016/j.kint.2022.06.008.

Abstract Views: 182

PDF Views: 0




  • Evolution in the Management of Type 2 Diabetes Mellitus: From Algorithmic to Individualized Approach

Abstract Views: 182  |  PDF Views: 0

Authors

Dr. Manish Maladkar
President-Medical & Regulatory Affairs, Dept. of Scientific, Aristo Pharmaceuticals Private Limited,, India

Abstract


Managing type 2 diabetes mellitus (T2DM) is a serious challenge due to the progressive nature of the disease and its effects on multiple organs. Advances in diabetes monitoring, therapy, and technology have accelerated the shift toward patientcentered care. In order to reduce diabetes distress, an individualized strategy offers a unique management plan for each patient improving medication adherence, patient satisfaction, and physical health outcomes. This editorial focuses on an individualized approach and the key factors that must be taken into account for diabetes management.

Keywords


type 2 diabetes mellitus, individualized approach, antidiabetic agents, complications.

References